These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 16966022

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rheumatoid arthritis: a review of the cutaneous manifestations.
    Sayah A, English JC.
    J Am Acad Dermatol; 2005 Aug; 53(2):191-209; quiz 210-2. PubMed ID: 16021111
    [Abstract] [Full Text] [Related]

  • 3. Pulmonary manifestations of rheumatoid arthritis.
    Gauhar UA, Gaffo AL, Alarcón GS.
    Semin Respir Crit Care Med; 2007 Aug; 28(4):430-40. PubMed ID: 17764060
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Granulomatous cutaneous rheumatoid vasculitis.
    Callen JP, Ahrens EM.
    J Rheumatol; 1988 Jun; 15(6):1005-8. PubMed ID: 3418621
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Unresolved issue: should patients with RA and a history of malignancy receive anti-TNF therapy?
    Brar A, Hiebert T, El-Gabalawy H.
    Nat Clin Pract Rheumatol; 2007 Mar; 3(3):120-1. PubMed ID: 17334334
    [No Abstract] [Full Text] [Related]

  • 11. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y, Markovits D, Rozin A, Toledano K, Nahir AM, Balbir-Gurman A.
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [Abstract] [Full Text] [Related]

  • 12. [Current therapeutic strategy for rheumatoid arthritis].
    Wollenhaupt J, Alten R, Burkhardt H, Edelmann E, Gromnica-Ihle E, Krause A, Krüger K, Manger B, Lorenz H, Müller-Ladner U, Nüsslein H, Pott HG, Tony H, Schneider M.
    MMW Fortschr Med; 2006 Oct 19; 148(42):38-42; quiz 43. PubMed ID: 17621798
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New therapeutics in rheumatoid arthritis.
    Savage C, St Clair EW.
    Rheum Dis Clin North Am; 2006 Feb 19; 32(1):57-74, viii. PubMed ID: 16504821
    [Abstract] [Full Text] [Related]

  • 16. Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.
    Flendrie M, Vissers WH, Creemers MC, de Jong EM, van de Kerkhof PC, van Riel PL.
    Arthritis Res Ther; 2005 Feb 19; 7(3):R666-76. PubMed ID: 15899052
    [Abstract] [Full Text] [Related]

  • 17. [Dermatologic conditions & nail manifestations in rheumatoid arthritis].
    Yoshida H, Yoshida S.
    Nihon Rinsho; 2005 Jan 19; 63 Suppl 1():225-8. PubMed ID: 15799350
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Atypical cutaneous tuberculosis in a patient with rheumatoid arthritis treated with infliximab.
    Asano Y, Kano Y, Shiohara T.
    Acta Derm Venereol; 2008 Jan 19; 88(2):183-4. PubMed ID: 18311458
    [No Abstract] [Full Text] [Related]

  • 20. Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis.
    Puéchal X, Miceli-Richard C, Mejjad O, Lafforgue P, Marcelli C, Solau-Gervais E, Steinfeld S, Villoutreix C, Trèves R, Mariette X, Guillevin L, Club Rhumatismes et Inflammation (CRI).
    Ann Rheum Dis; 2008 Jun 19; 67(6):880-4. PubMed ID: 18037625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.